SANUWAVE Health Inc is committed to delivering innovative solutions in the field of regenerative medicine. With a focus on advanced wound care, the company aims to improve patient outcomes and quality of life. Their corporate philosophy is centered around pioneering technology, research, and clinical studies to develop safe and effective treatments for chronic and acute wounds. SANUWAVE Health Inc strives for collaboration with healthcare professionals and has a strong dedication to patient-centric care. Through their commitment to innovation, research, and customer satisfaction, SANUWAVE Health Inc continues to be a leader in the field of regenerative medicine.

SANUWAVE Health Inc is primarily present in the United States.

SANUWAVE Health Inc has achieved several significant milestones in its history. These include gaining regulatory approvals for its flagship product, dermaPACE®, a non-invasive shockwave device designed to promote healing of chronic wounds. The company has also expanded its market presence through strategic partnerships and distribution agreements, enabling broader access to its innovative medical technologies. SANUWAVE Health Inc has demonstrated its commitment to research and development, continually improving its product offerings and seeking new applications for its technology. The company's milestones reflect its dedication to advancing healthcare solutions and improving patient outcomes.

SANUWAVE Health Inc. is a renowned medical technology company specializing in the development and commercialization of non-invasive regenerative medicine solutions. With a strong focus on using innovative shockwave technology, SANUWAVE Health Inc. aims to improve patient healing and recovery in various medical fields. The company has a rich history and has been at the forefront of biomedical engineering advancements for over a decade. Having pioneered the use of shockwave therapy for wound management, SANUWAVE Health Inc.'s groundbreaking solutions have helped countless patients with acute and chronic conditions. Their commitment to research, development, and improving patient outcomes has solidified their position as a leader in the regenerative medicine industry.

The main competitors of SANUWAVE Health Inc in the market include companies like Acelity, Medtronic, Smith & Nephew, and Zimmer Biomet.

SANUWAVE Health Inc is primarily active in the healthcare industry.

The business model of SANUWAVE Health Inc focuses on the development and commercialization of advanced regenerative medicine products and devices primarily for the global wound care market. SANUWAVE aims to provide innovative solutions that promote the healing process, including the use of shockwave technology. By leveraging its expertise in the medical field, SANUWAVE aims to improve patient outcomes and reduce healthcare costs associated with chronic and acute wounds. Moreover, SANUWAVE Health Inc is committed to research, development, and strategic partnerships to advance its product portfolio and expand its reach in the healthcare industry.

Коефициентът на цена спрямо печалбата (КЦП) на SANUWAVE Health е 0.

Коефициентът на цена към оборот (KUV) на SANUWAVE Health е 0,05.

AlleAktien качественият резултат за SANUWAVE Health е 4/10.

очаквана SANUWAVE Health оборотът е 240,19 млн. USD.

Печалбата за SANUWAVE Health в момента не може да бъде изчислена.

SANUWAVE Health Inc is a leading company in the field of regenerative medicine, offering innovative therapy and diagnostic solutions for a variety of diseases. The company is headquartered in Suwanee, Georgia, USA and was founded in 2005. SANUWAVE's business model is based on the development and marketing of medical devices and procedures that enable rapid and effective healing of chronic and acute wounds, pain, and orthopedic conditions. The company focuses on the development of high-frequency shockwave therapies that stimulate the body's own regenerative processes and support healing. SANUWAVE's product portfolio currently includes two main areas, namely the orthopedic business and the wound care business. For the orthopedic field, SANUWAVE offers the OrthoPACE® device, which can treat painful musculoskeletal conditions. Shockwave therapy can be used for various orthopedic complaints such as tendon tears, muscle and ligament injuries, bone fractures, arthritis, back pain, and inflammation. For the wound care field, SANUWAVE offers the Pulsed Acoustic Cellular Expression (PACE) technology device, which allows for faster and more effective healing of chronic wounds such as diabetic foot ulcers, venous ulcers, or pressure ulcers. This technology is based on high-frequency shockwaves that create a type of "microtrauma" on the wound surface, stimulating the growth of new blood vessels and tissue. SANUWAVE follows a multi-stage distribution model and works closely with doctors, clinics, healthcare centers, and hospitals to provide its products and services. The company has a dedicated sales team that communicates with customers to educate them about the benefits of SANUWAVE products from a medical perspective. In addition, the company offers training and education to inform healthcare professionals about the application of shockwave therapies in practice. SANUWAVE also has a strong research and development department that constantly develops new products and applications to expand the product range and meet the needs of patients and medical professionals. In summary, SANUWAVE's business model is based on the development and marketing of innovative high-frequency shockwave therapies for orthopedic and wound care. By using PACE technology, the company offers products that enable fast and effective healing of acute and chronic wounds, inflammation, and pain. Thanks to a dedicated sales team and a strong research and development department, SANUWAVE is able to provide its customers with the latest and most advanced solutions in regenerative medicine.

SANUWAVE Health разпределя дивидента от 0 USD на плащания годишно.

Дивидентата за SANUWAVE Health в момента не може да бъде изчислена или компанията не разпределя дивиденти.

ISIN на SANUWAVE Health е US80303D1072.

Тикерът на SANUWAVE Health е SNWV.

През последните 12 месеца SANUWAVE Health изплати дивиденда в размер на . Това съответства на дивидендна доходност от около . За следващите 12 месеца се очаква SANUWAVE Health да изплати дивиденда в размер на 0 USD.

Дивидентната доходност на SANUWAVE Health в момента е .

SANUWAVE Health изплаща дивидент на тримесечие. Той се разпределя в месеците .

SANUWAVE Health платеше дивиденда всяка година през последните 0 години.

За идните 12 месеца се очакват дивиденти в размер на 0 USD. Това съответства на дивидентна доходност от 0 %.

SANUWAVE Health се отнася за сектор 'Здраве'.

За да получите последното дивидентно плащане от SANUWAVE Health на 7.09.2024 г. в размер на 0 USD, трябваше да притежавате акцията в портфейла си преди Ex-деня на 7.09.2024 г..

Последното дивидентно плащане беше извършено на 7.09.2024 г..

През година 2023 SANUWAVE Health изплати 0 USD под формата на дивиденти.

Дивидентите от SANUWAVE Health се изплащат в USD.